Tvardi Therapeutics, Inc. SEC filings TVRD
Tvardi Therapeutics, Inc. has 809 filings in SEC EDGAR's recent list, going back to Dec 6, 2005. Its latest annual report, Form ARS, was filed on Apr 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 14, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2026 | Aug 14, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 30, 2026 | Jul 30, 2026 |
| 8-K |
Current report
Other events
|
Jul 17, 2026 | Jul 17, 2026 |
| 424B5 | Prospectus supplement | Jul 17, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 7, 2026 | Jul 7, 2026 |
| 4 | Insider transaction | Jun 11, 2026 | Jun 9, 2026 |
| 4 | Insider transaction | Jun 11, 2026 | Jun 9, 2026 |
| 4 | Insider transaction | Jun 11, 2026 | Jun 9, 2026 |
| 4 | Insider transaction | Jun 11, 2026 | Jun 9, 2026 |
| 4 | Insider transaction | Jun 11, 2026 | Jun 9, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 11, 2026 | Jun 9, 2026 |
| EFFECT | Filing | May 13, 2026 | — |
| EFFECT | Filing | May 12, 2026 | — |
| POS AM | Filing | May 8, 2026 | — |
| CORRESP | Letter to the SEC | May 8, 2026 | — |
| 10-Q | Quarterly report | May 8, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 8, 2026 | May 8, 2026 |
| UPLOAD | Letter from the SEC | May 7, 2026 | — |
| S-3 | Shelf registration | May 1, 2026 | — |
| ARS | Annual report to shareholders | Apr 23, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 23, 2026 | — |
| DEF 14A | Proxy statement | Apr 23, 2026 | Jun 9, 2026 |
| S-8 | Employee stock plan registration | Apr 1, 2026 | — |
| POS EX | Filing | Apr 1, 2026 | — |
| 424B3 | Prospectus | Apr 1, 2026 | — |
| 10-K | Annual report | Mar 31, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 31, 2026 | Mar 31, 2026 |
| 424B3 | Prospectus | Mar 6, 2026 | — |
| 8-K |
Current report
Other events
|
Mar 6, 2026 | Mar 6, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| 4 | Insider transaction | Feb 2, 2026 | Jan 29, 2026 |
| 4 | Insider transaction | Feb 2, 2026 | Jan 29, 2026 |
| 4 | Insider transaction | Feb 2, 2026 | Jan 29, 2026 |
| 4 | Insider transaction | Feb 2, 2026 | Jan 29, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 16, 2026 | Jan 16, 2026 |
| 8-K |
Current report
Officer or director change
|
Dec 18, 2025 | Dec 16, 2025 |
| 4 | Insider transaction | Dec 18, 2025 | Dec 16, 2025 |
| 4 | Insider transaction | Dec 18, 2025 | Dec 16, 2025 |
| 4 | Insider transaction | Dec 18, 2025 | Dec 16, 2025 |
| 4 | Insider transaction | Dec 18, 2025 | Dec 16, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 19, 2025 | Nov 19, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| 424B3 | Prospectus | Nov 13, 2025 | — |
| 8-K |
Current report
Results of operations
|
Nov 13, 2025 | Nov 13, 2025 |
| 10-Q | Quarterly report | Nov 13, 2025 | Sep 30, 2025 |
| S-8 | Employee stock plan registration | Oct 20, 2025 | — |
| S-1/A | Amended registration statement | Oct 20, 2025 | — |
| 8-K |
Current report
Other events
|
Oct 14, 2025 | Oct 13, 2025 |
| S-1/A | Amended registration statement | Oct 7, 2025 | — |
| 8-K |
Current report
Results of operations
|
Aug 14, 2025 | Aug 14, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 14, 2025 | — |
| 10-Q | Quarterly report | Aug 14, 2025 | Jun 30, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 8, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 5, 2025 | — |
| 4 | Insider transaction | Aug 5, 2025 | Jul 7, 2025 |
| 8-K |
Current report
Officer or director change
|
Jul 14, 2025 | Jul 8, 2025 |
| 8-K |
Current report
Other events
|
Jun 9, 2025 | Jun 6, 2025 |
| UPLOAD | Letter from the SEC | Jun 5, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jun 2, 2025 | — |
| S-1 | Registration statement | May 30, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
May 27, 2025 | May 27, 2025 |
| 8-K |
Current report
Results of operations, Auditor change
|
May 13, 2025 | May 12, 2025 |
| 8-K/A |
Amended current report
Acquisition or sale of assets
|
May 13, 2025 | Apr 15, 2025 |
| 10-Q | Quarterly report | May 13, 2025 | Mar 31, 2025 |
| 4/A | Filing | May 2, 2025 | Apr 15, 2025 |
| 4/A | Filing | May 2, 2025 | Apr 15, 2025 |
| 3 | Initial insider ownership | May 2, 2025 | Apr 15, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | May 2, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | May 2, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Apr 22, 2025 | — |
| 4 | Insider transaction | Apr 21, 2025 | Apr 17, 2025 |
| 4 | Insider transaction | Apr 21, 2025 | Apr 17, 2025 |
| 4 | Insider transaction | Apr 21, 2025 | Apr 17, 2025 |
| 4 | Insider transaction | Apr 21, 2025 | Apr 17, 2025 |
| 4 | Insider transaction | Apr 21, 2025 | Apr 17, 2025 |
| 4 | Insider transaction | Apr 21, 2025 | Apr 17, 2025 |
| 4 | Insider transaction | Apr 21, 2025 | Apr 17, 2025 |
| 4 | Insider transaction | Apr 21, 2025 | Apr 17, 2025 |
| 4 | Insider transaction | Apr 21, 2025 | Apr 17, 2025 |
| 4 | Insider transaction | Apr 21, 2025 | Apr 17, 2025 |
| 4 | Insider transaction | Apr 21, 2025 | Apr 17, 2025 |
| 4 | Insider transaction | Apr 21, 2025 | Apr 17, 2025 |
| 4 | Insider transaction | Apr 17, 2025 | Apr 15, 2025 |
| 4 | Insider transaction | Apr 17, 2025 | Apr 15, 2025 |
| 4 | Insider transaction | Apr 17, 2025 | Apr 15, 2025 |
| 4 | Insider transaction | Apr 17, 2025 | Apr 15, 2025 |
| 4 | Insider transaction | Apr 17, 2025 | Apr 15, 2025 |
| 4 | Insider transaction | Apr 17, 2025 | Apr 15, 2025 |
| 4 | Insider transaction | Apr 17, 2025 | Apr 15, 2025 |
| 4 | Insider transaction | Apr 17, 2025 | Apr 15, 2025 |
| 4 | Insider transaction | Apr 17, 2025 | Apr 15, 2025 |
| 4 | Insider transaction | Apr 17, 2025 | Apr 15, 2025 |
| 3 | Initial insider ownership | Apr 17, 2025 | Apr 15, 2025 |
| 3 | Initial insider ownership | Apr 17, 2025 | Apr 15, 2025 |
| 3 | Initial insider ownership | Apr 17, 2025 | Apr 15, 2025 |
| 3 | Initial insider ownership | Apr 17, 2025 | Apr 15, 2025 |
| 3 | Initial insider ownership | Apr 17, 2025 | Apr 15, 2025 |
| 3 | Initial insider ownership | Apr 17, 2025 | Apr 15, 2025 |
| 3 | Initial insider ownership | Apr 17, 2025 | Apr 15, 2025 |
| 3 | Initial insider ownership | Apr 17, 2025 | Apr 15, 2025 |
| 3 | Initial insider ownership | Apr 17, 2025 | Apr 15, 2025 |
| 3 | Initial insider ownership | Apr 17, 2025 | Apr 15, 2025 |
| 3 | Initial insider ownership | Apr 17, 2025 | Apr 15, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Apr 16, 2025 | — |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Change to shareholder rights, Change in control, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure, Other events
|
Apr 15, 2025 | Apr 15, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 11, 2025 | Apr 11, 2025 |
| 8-K |
Current report
Shareholder vote results, Other events
|
Apr 1, 2025 | Apr 1, 2025 |
| 425 | Filing | Mar 24, 2025 | — |
| 8-K |
Current report
Other events
|
Mar 24, 2025 | Mar 24, 2025 |
| 10-K | Annual report | Mar 11, 2025 | Dec 31, 2024 |
| 4 | Insider transaction | Mar 4, 2025 | Feb 28, 2025 |
| 4 | Insider transaction | Mar 4, 2025 | Feb 28, 2025 |
| SEC STAFF LETTER | Filing | Feb 14, 2025 | — |
| EFFECT | Filing | Feb 14, 2025 | — |
| 424B3 | Prospectus | Feb 14, 2025 | — |
| CORRESP | Letter to the SEC | Feb 14, 2025 | — |
| S-4/A | Filing | Feb 14, 2025 | — |
| CORRESP | Letter to the SEC | Feb 13, 2025 | — |
| UPLOAD | Letter from the SEC | Feb 11, 2025 | — |
| 4 | Insider transaction | Feb 6, 2025 | Feb 4, 2025 |
| S-4/A | Form s-4/a | Jan 27, 2025 | — |
| CORRESP | Letter to the SEC | Jan 24, 2025 | — |
| 425 | Filing | Jan 21, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 21, 2025 | Jan 16, 2025 |
| 425 | Filing | Jan 17, 2025 | — |
| 8-K |
Current report
Other events
|
Jan 17, 2025 | Jan 14, 2025 |
| SEC STAFF LETTER | Filing | Jan 16, 2025 | — |
| UPLOAD | Letter from the SEC | Jan 16, 2025 | — |
| 425 | Filing | Dec 30, 2024 | — |
| 8-K |
Current report
Bylaw or fiscal year change
|
Dec 30, 2024 | Dec 30, 2024 |
| 425 | Filing | Dec 20, 2024 | — |
| 8-K/A | Amended current report | Dec 20, 2024 | Dec 17, 2024 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Dec 18, 2024 | — |
| S-4 | Registration for a merger or exchange | Dec 18, 2024 | — |
| 425 | Filing | Dec 18, 2024 | — |
| 8-K |
Current report
Material agreement, Change in control, Officer or director change, Other events
|
Dec 18, 2024 | Dec 17, 2024 |
| 8-K |
Current report
Listing notice
|
Nov 22, 2024 | Nov 19, 2024 |
| 10-Q | Quarterly report | Nov 14, 2024 | Sep 30, 2024 |
| 4 | Insider transaction | Nov 6, 2024 | Nov 4, 2024 |
| SC 13D | Ownership over 5% (active) | Oct 30, 2024 | — |
| 10-Q | Quarterly report | Aug 14, 2024 | Jun 30, 2024 |
| 4 | Insider transaction | Aug 2, 2024 | Aug 1, 2024 |
| 8-K |
Current report
Listing notice
|
Aug 1, 2024 | Jul 31, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Jul 8, 2024 | — |
| 8-K |
Current report
Exit or restructuring costs
|
Jun 18, 2024 | Jun 14, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 12, 2024 | Jun 12, 2024 |
| 424B5 | Prospectus supplement | Jun 7, 2024 | — |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Jun 7, 2024 | Jun 4, 2024 |
| 4 | Insider transaction | Jun 6, 2024 | Jun 4, 2024 |
| 4 | Insider transaction | Jun 6, 2024 | Jun 4, 2024 |
| 4 | Insider transaction | Jun 6, 2024 | Jun 4, 2024 |
| 4 | Insider transaction | Jun 6, 2024 | Jun 4, 2024 |
| 4 | Insider transaction | Jun 6, 2024 | Jun 4, 2024 |
| 10-Q | Quarterly report | May 13, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 13, 2024 | May 13, 2024 |
| 4 | Insider transaction | May 6, 2024 | May 2, 2024 |
| DEFA14A | Additional proxy material | Apr 22, 2024 | — |
| ARS | Annual report to shareholders | Apr 22, 2024 | Dec 31, 2023 |
| DEF 14A | Proxy statement | Apr 22, 2024 | Jun 4, 2024 |
| PRE 14A | Preliminary proxy statement | Apr 12, 2024 | Jun 4, 2024 |
| 4 | Insider transaction | Apr 9, 2024 | Apr 5, 2024 |
| 4 | Insider transaction | Apr 9, 2024 | Apr 5, 2024 |
| 8-K |
Current report
Officer or director change
|
Mar 22, 2024 | Mar 19, 2024 |
| S-8 | Employee stock plan registration | Mar 6, 2024 | — |
| 10-K | Annual report | Mar 6, 2024 | Dec 31, 2023 |
| 4 | Insider transaction | Mar 4, 2024 | Feb 29, 2024 |
| 4 | Insider transaction | Mar 4, 2024 | Feb 29, 2024 |
| 4 | Insider transaction | Mar 4, 2024 | Feb 29, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 4, 2024 | Mar 4, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 13, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 13, 2024 | — |
| 4 | Insider transaction | Feb 12, 2024 | Feb 8, 2024 |
| 4 | Insider transaction | Feb 12, 2024 | Feb 8, 2024 |
| 4 | Insider transaction | Feb 12, 2024 | Feb 8, 2024 |
| 4 | Insider transaction | Feb 12, 2024 | Feb 8, 2024 |
| 4 | Insider transaction | Feb 5, 2024 | Feb 1, 2024 |
| 4 | Insider transaction | Feb 5, 2024 | Feb 1, 2024 |
| 4 | Insider transaction | Feb 5, 2024 | Feb 1, 2024 |
| 4 | Insider transaction | Feb 5, 2024 | Feb 1, 2024 |
| 4 | Insider transaction | Feb 5, 2024 | Feb 1, 2024 |
| 8-K |
Current report
Listing notice
|
Feb 2, 2024 | Feb 1, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Jan 29, 2024 | — |
| 8-K |
Current report
Exit or restructuring costs, Regulation FD disclosure, Other events
|
Jan 22, 2024 | Jan 17, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 18, 2023 | Dec 18, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 13, 2023 | Nov 13, 2023 |
| 10-Q | Quarterly report | Nov 13, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2023 | Nov 13, 2023 |
| 4 | Insider transaction | Nov 3, 2023 | Nov 2, 2023 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Nov 2, 2023 | Nov 1, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 7, 2023 | Aug 7, 2023 |
| 10-Q | Quarterly report | Aug 7, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2023 | Aug 7, 2023 |
| 4 | Insider transaction | Aug 4, 2023 | Aug 3, 2023 |
| 4 | Insider transaction | Aug 4, 2023 | Aug 2, 2023 |
| 3 | Initial insider ownership | Aug 4, 2023 | Aug 2, 2023 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Aug 3, 2023 | Aug 2, 2023 |
| SC 13G/A | Amended ownership over 5% (passive) | Jul 25, 2023 | — |
| 3 | Initial insider ownership | Jul 25, 2023 | Aug 9, 2022 |
| SC 13G/A | Amended ownership over 5% (passive) | Jul 7, 2023 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- TVRD (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Sugar Land, TX
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1346830
- Former names
- Cara Therapeutics, Inc. (until Apr 11, 2025); Cara Therapeutics Inc (until Jul 21, 2010)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.